Citius Pharmaceuticals, Inc. (CTXR) Free cash flow 2018–2022
Citius Pharmaceuticals, Inc. (CTXR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$28.4MFY2022 · since FY2018: -$11.3M → -$28.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$28.4M | -17.0% |
| FY2021 | -$24.3M | — |
| FY2018 | -$11.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTXR financial trends
CTXR RevenueCTXR Net incomeCTXR Net marginCTXR Gross profitCTXR Gross marginCTXR Operating incomeCTXR Operating marginCTXR Operating cash flowCTXR Capital expendituresCTXR Return on equityCTXR Stock buybacksCTXR Dividends paidCTXR Total assetsCTXR Total liabilitiesCTXR Shareholders’ equityCTXR overview →